Citadel Advisors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-144,792
| Closed | -$1.44M | – | 7042 |
|
|
2022
Q3 | $1.44M | Sell |
144,792
-1,589
| -1% | -$15.8K | ﹤0.01% | 3062 |
|
|
2022
Q2 | $1.45M | Sell |
146,381
-749,281
| -84% | -$7.42M | ﹤0.01% | 3032 |
|
|
2022
Q1 | $8.82M | Sell |
895,662
-1,118
| -0.1% | -$11K | ﹤0.01% | 1514 |
|
|
2021
Q4 | $8.82M | Sell |
896,780
-3,101
| -0.3% | -$30.5K | ﹤0.01% | 1564 |
|
|
2021
Q3 | $8.77M | Buy |
899,881
+2,108
| +0.2% | +$20.5K | ﹤0.01% | 1558 |
|
|
2021
Q2 | $8.68M | Buy |
897,773
+2,340
| +0.3% | +$22.6K | ﹤0.01% | 1565 |
|
|
2021
Q1 | $8.69M | Buy |
+895,433
| New | +$8.69M | ﹤0.01% | 1551 |
|